Harvard’s Wyss Institute collaborates with GBS Inc. on eRapid-based COVID-19 diagnostic
Combination of the Wyss' electrochemical sensing technology with GBS's transistor technology could enable fast, multiplexed, low-cost COVID-19 biomarker analysis in ...